Clinical Trials Directory

Trials / Unknown

UnknownNCT03903367

Thoracic Paravertebral Block Versus IV Fentanyl Infusion

Bilateral Continous Thoracic Paravertebral Block Versus IV Fentanyl Infusion For Perioperative Analgesia in Patients Undergoing Cardiac Surgery Through Median Sternotomy

Status
Unknown
Phase
Phase 1 / Phase 2
Study type
Interventional
Enrollment
44 (estimated)
Sponsor
Beni-Suef University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

High-quality analgesia during and following cardiac surgery is infrequently obtained, Sternotomy and thoracotomy is associated with significant pain that resulte in hypoventilation, atelectasis, and hypoxemia,Pain management is rarley a priority in the immediate postoperative care of these patients, who frequently require mechanical ventilation in an intensive care environment

Detailed description

Paravertebral nerve blocks (PVBs) can provide excellent intraoperative anaesthetic and postoperative analgesic conditions with less side effects and fewer contraindications than central neural blocks,Bilateral PVB has been successfully used in the thoracic, abdominal, and pelvic regions(12). Paravertebral analgesia is produced by placing local anaesthetic (LA) alongside the vertebral column, close to the exit of the spinal nerves(13).. Traditionally, profound intraoperative analgesia has been provided by using high doses of opioids to suppress hormonal and metabolic stress responses to surgical stimuli. This regimen resulted in improved morbidity and mortality after cardiac surgery(14).

Conditions

Interventions

TypeNameDescription
DRUGFentanyl Citratestandard GA and receive fentanyl infusion 2 mcg/kg/h after tracheal intubation and stopped at the end of the operation ,When HR or MBP increased ≥20% from base line readings, incremental dose of fentanyl will be given (2mcg /kg).

Timeline

Start date
2019-05-01
Primary completion
2019-12-01
Completion
2019-12-01
First posted
2019-04-04
Last updated
2019-04-04

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03903367. Inclusion in this directory is not an endorsement.